Antigen identification starting from the genome: A “reverse vaccinology” approach applied to menb

Methods in Molecular Biology

Volumn 799, Issue , 2012, Pages 361-403

  Palumbo, Emmanuelle ^a   Fiaschi, Luigi ^a   Brunelli, Brunella ^a   Marchi, Sara ^a   Savino, Silvana ^a   Pizza, Mariagrazia ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Antigen expression and purification; Antigen selection; Bactericidal assay; Genomics; Neisseria meningitidis; Reverse vaccinology; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; PRIMER DNA;

AFFINITY CHROMATOGRAPHY; AGAR GEL ELECTROPHORESIS; ARTICLE; BIOLOGY; BIOTECHNOLOGY; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC MENINGITIS; FLOW CYTOMETRY; GENETICS; GENOMICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR CLONING; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BIOTECHNOLOGY; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; DNA PRIMERS; DRUG DESIGN; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENOMICS; HUMANS; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS, SEROGROUP B; POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS SEROGROUP B;

EID: 80555135938     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-346-2_21     Document Type: Chapter

References (24)

1. Keating GM, Noble S (2003) Recombinant hepatitis B vaccine (Engerix-B (R))-A review of its immunogenicity and protective efficacy against hepatitis B. Drugs 63: 1021–1051.
2. Cutts FT, Franceschi S, Goldie S et al (2007) Human papillomavirus and HPV vaccines: a review. Bull World Health Org 85: 719–726.
3. Pizza M, Covacci A, Bartoloni A et al (1989) Mutants of pertussis toxin suitable for vaccine development. Science 246: 497–500.
4. Stephens DS (2007) Conquering the meningococcus. Fems Micro Rev 31: 3–14.
5. Riordan A (2010) The implications of vaccines for prevention of bacterial meningitis. Curr Opin Neurol 23: 319–324.
6. Pizza M, Scarlato V, Masignani V et al (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287: 1816–1820.
7. Plotkin SA (2008) Correlates of vaccine-induced immunity. Clin Infect Dis 47: 401–409.
8. Medini D, Serruto D, Parkhill J et al (2008) Microbiology in the post-genomic era. Nature Rev Microbiol 6: 419–430.
9. Margarit I, Rinaudo CD, Galeotti CL et al (2009) Preventing bacterial infections with pilus-based vaccines: the Group B Streptococcus paradigm. J Infect Dis 199: 108–115.
10. Bagnoli F, Baudner B, Mishra R et al (2011) Designing the next generation of vaccines for global public health. OMICS: J Integrat Biol 17. [Epub ahead of print].
11. Scarselli M, Aricò B, Brunelli B et al (2011) Rational design of a meningococcal antigen inducing broad protective immunity. Sci Transl Med 3(91): 91–62.
12. Capecchi B, Adu-Bobie J, Di Marcello F et al (2005) Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells. Mol Microbiol 55: 687–698.
13. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. CSHL Press,
14. Coligan JE, Dunn BM, Ploegh HL et al (2002) Curr Prot Prot Sci 1: 6.0.1–6.0.4.
15. Scopes RK (1994) Protein purification: principles and practices. Springer, New York.
16. Hopkins TR (1991) Physical and chemical cell disruption for the recovery of intracellular proteins, in: Seetharam R, Sharma SK (Eds.), Purification and analysis of recombinant proteins, Marcel Dekker, New York, pp. 57–83.
17. Bornhorst JA, Falke JJ (2000) Purification of proteins using polyhistidine affinity tags. Methods Enzymol 326: 245–254.
18. Kneusel RE, Crowe J, Wulbeck M, Ribbe J (2000) Procedures for the analysis and purification of His-tagged proteins, in: Rapley R (Ed.), The Nucleic Acid Protocols Handbook, Springer, pp. 921–934.
19. Feavers I, Walker B (2010) Functional Antibody Assays. Meth Molec Biol 626: 199–211.
20. Giuliani MM, du-Bobie J, Comanducci M et al (2006) A universal vaccine for serogroup B meningococcus. Proc Nat Acad Sci USA 103: 10834–10839.
21. Qin L, Gilbert PB, Corey L et al (2007) A framework for assessing immunological correlates of protection in vaccine trials. J Infect Dis 196: 1304–1312.
22. Welsch JA, Moe GR, Rossi R et al (2003) Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity. J Infect Dis 188: 1730–1740.
23. Tjalsma H, Bolhuis A, Jongbloed JDH et al (2000) Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev 64: 515–547.
24. Tjalsma H, Antelmann H, Jongbloed JDH et al (2004) Proteomics of protein secretion by Bacillus subtilis: Separating the “secrets” of the secretome. Microbiol Mol Biol Rev 68: 207–233.